Waddell & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
10,973
-38
-0.3% -$8.86K 0.14% 48
2026
Q1
$2.69M Buy
11,011
+536
+5% +$125K 0.15% 39
2025
Q4
$2.17M Buy
10,475
+410
+4% +$81.1K 0.15% 40
2025
Q3
$1.87M Buy
10,065
+1,856
+23% +$318K 0.16% 42
2025
Q2
$1.25M Buy
8,209
+1,773
+28% +$273K 0.13% 51
2025
Q1
$1.07M Sell
6,436
-350
-5% -$54.8K 0.13% 48
2024
Q4
$981K Buy
6,786
+620
+10% +$96.1K 0.1% 54
2024
Q3
$999K Buy
6,166
+228
+4% +$36.3K 0.12% 52
2024
Q2
$868K Buy
5,938
+340
+6% +$50.6K 0.11% 55
2024
Q1
$886K Sell
5,598
-82
-1% -$13.1K 0.12% 53
2023
Q4
$877K Sell
5,680
-3,195
-36% -$490K 0.12% 51
2023
Q3
$1.38M Sell
8,875
-394
-4% -$65K 0.2% 45
2023
Q2
$1.53M Buy
9,269
+151
+2% +$24.4K 0.23% 38
2023
Q1
$1.41M Sell
9,118
-254
-3% -$41K 0.22% 39
2022
Q4
$1.66M Buy
9,372
+122
+1% +$21.1K 0.28% 35
2022
Q3
$1.51M Sell
9,250
-494
-5% -$83.6K 0.29% 33
2022
Q2
$1.73M Buy
9,744
+483
+5% +$86.1K 0.35% 24
2022
Q1
$1.64M Sell
9,261
-51
-0.5% -$8.68K 0.26% 27
2021
Q4
$1.59M Sell
9,312
-18
-0.2% -$2.95K 0.25% 27
2021
Q3
$1.51M Buy
9,330
+5,176
+125% +$883K 0.26% 25
2021
Q2
$684 Buy
+4,154
New +$688K 0.1% 51

Other funds holding JNJ

Waddell & Associates's JNJ Position: Q2 2026 in Review

Waddell & Associates reduced its Johnson & Johnson (JNJ) stake by 0.35% in Q2 2026, selling an estimated $8.86K and leaving 10,973 shares worth $2.79M. The position accounts for 0.14% of the portfolio, ranked #48.

Waddell & Associates first reported a position in JNJ in Q2 2021 and has held it in 21 quarters since. 1,809 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Waddell & Associates held 10,973 shares of Johnson & Johnson worth $2.79M as of Q2 2026.
  • Waddell & Associates sold 38 Johnson & Johnson shares in Q2 2026, an estimated $8.86K.
  • Johnson & Johnson made up 0.14% of Waddell & Associates's portfolio in Q2 2026, its #48 holding.
  • Waddell & Associates first reported a position in Johnson & Johnson in Q2 2021 and has held it in 21 quarters since.
  • 1,809 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.